Predicting Severe Outcomes Among Children Hospitalized With Community-acquired Pneumonia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

6000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, investigators aimed to develop and validate a risk score to predict severe outcomes (e.g., mortality and ICU admission) in children who were admitted to the Children's Hospital of Fudan University between 2017 and 2022 due to community-acquired pneumonia (CAP). The objectives were as follows.

1. Develop a risk prediction model based on demographic, comorbidity, clinical characteristics, laboratory data, and chest radiographic reports to predict severe outcomes among children hospitalized with CAP;
2. Develop a risk scoring system and determine the cut-off point;
3. Externally validate the easy-to-use risk score.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Predictors of Severity in Pediatric Community-Acquired Pneumonia at Assiut University Children's Hospital

NCT07279675

Community-Acquired Pneumonia Pediatric Pneumonia Lower Respiratory Tract Infection

NOT_YET_RECRUITING

Predictors of Improvement and Deterioration of Community Acquired Pneumonia in Children

NCT06720441

Predictors of Improvement and Deterioration of Community Acquired Pneumonia

NOT_YET_RECRUITING

Factors Associated With Complicated Pneumonia in Paedatrics

NCT05792904

Complicated Pneumonia in Pediatrics

UNKNOWN

Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia

NCT03996967

Pneumonia, Bacterial Viral Infection Clinical Pneumonia +3 more

COMPLETED

Assessing Effectiveness of Community Acquired Pneumonia Treatment by Continuous Pneumonia Severity Score

NCT04135183

Community-acquired Pneumonia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia Child Prognosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

children hospitalized with community-acquired pneumonia

exposures of interest: epidemiological data, clinical characteristics, laboratory data, and chest radiographic reports

Intervention Type OTHER

epidemiological data (e.g., age, sex, and residential area), clinical characteristics (e.g., fever, cough, and wheeze), laboratory data (e.g., white blood cell, c-reaction protein, and procalcitonin), and chest radiographic reports (e.g., X-ray, CT, and ultrasound)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

exposures of interest: epidemiological data, clinical characteristics, laboratory data, and chest radiographic reports

epidemiological data (e.g., age, sex, and residential area), clinical characteristics (e.g., fever, cough, and wheeze), laboratory data (e.g., white blood cell, c-reaction protein, and procalcitonin), and chest radiographic reports (e.g., X-ray, CT, and ultrasound)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged between 29 days and 18 years old;
2. Admitted to hospital with signs or symptoms of acute infection (eg, fever) and acute respiratory illness (eg, cough), and radiographic evidence of pneumonia.

Exclusion Criteria

1. Pneumonia developed 48 hours after admission or intubation;
2. Chronic pneumonia, tuberculosis, tracheobronchial foreign bodies, aspiration pneumonia, parasitic lung disease, and diffuse pulmonary interstitial/parenchyma disease.

Minimum Eligible Age

29 Days

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No